Earnings calendar/ETON
Eton Pharmaceuticals, Inc. (ETON)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 5, 2026
Consensus estimate row
EPS target
$0.37
Street estimate
Revenue target
$42.0M
Street estimate
Trailing EPS (avg 4Q)
$0.12
Beat rate last 4: 25%
Latest EPS YoY
+530.0%
vs 2025-08-07
Latest revenue YoY
+98.6%
How results look so far
Trailing revenue (avg 4Q)
$26.4M
Printed quarters
EPS beat rate (4Q)
25%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 13, 2026
EPS beat
EPS actual / est
$0.43 / $0.19
+126.6%
Revenue actual / est
$37.6M / $27.1M
+38.7%
Result
Target reached
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/5/2026upcoming | $0.37 | Pending | — | $42.0M | Pending | — |
| 8/13/2026 | $0.19 | $0.43 | +126.6% | $27.1M | $37.6M | +38.7% |
| 5/14/2026 | $0.10 | $0.05 | -50.0% | $22.3M | $24.3M | +8.8% |
| 5/12/2026upcoming | $0.10 | Pending | — | $22.3M | Pending | — |
| 3/19/2026 | $0.12 | $0.05 | -58.3% | $20.0M | $21.3M | +6.5% |
| 3/17/2026upcoming | $0.19 | Pending | — | — | Pending | — |
| 11/6/2025 | $0.16 | $-0.07 | -143.8% | $20.5M | $22.5M | +9.7% |
| 8/7/2025 | $-0.01 | $-0.10 | -900.0% | $20.5M | $18.9M | -7.6% |
| 5/13/2025 | $0.09 | $0.07 | -22.2% | $15.1M | $17.3M | +14.2% |
| 3/18/2025 | $-0.02 | $-0.02 | 0.0% | $14.3M | $11.6M | -18.7% |
| 11/12/2024 | $0.00 | $0.02 | +400.0% | $10.5M | $10.3M | -2.0% |
| 8/8/2024 | $-0.07 | $-0.12 | -71.4% | $9.7M | $9.1M | -6.4% |
| 5/9/2024 | $-0.07 | $-0.03 | +57.1% | $8.8M | $8.0M | -9.5% |
| 3/14/2024 | $-0.04 | $-0.09 | -125.0% | $7.7M | $7.3M | -5.0% |
| 11/9/2023 | $-0.10 | $-0.02 | +80.0% | $6.3M | $7.0M | +12.3% |
| 8/10/2023 | $-0.09 | $0.15 | +266.7% | $10.1M | $12.0M | +18.9% |
| 5/11/2023 | $-0.14 | $-0.10 | +28.6% | $6.5M | $5.3M | -18.5% |
| 3/16/2023 | $0.01 | $0.04 | +300.0% | $4.6M | $8.5M | +86.4% |
| 11/10/2022 | $-0.15 | $-0.12 | +20.0% | $3.0M | $3.2M | +5.6% |
| 8/11/2022 | $-0.01 | $-0.06 | -300.0% | $7.8M | $7.4M | -5.7% |
| 5/12/2022 | $-0.08 | $-0.21 | -162.5% | $2.0M | $2.2M | +6.7% |
| 3/16/2022 | $0.19 | $0.04 | -78.9% | — | $6.1M | — |
| 11/15/2021 | $-0.14 | $-0.24 | -71.4% | $663,962.06 | $775,000 | +16.7% |
| 8/16/2021 | $-0.14 | $-0.08 | +42.9% | $4.8M | $3.1M | -35.6% |
| 5/13/2021 | $0.19 | $0.19 | 0.0% | $12.1M | $11.9M | -1.3% |
| 3/16/2021 | $-0.26 | $-0.32 | -23.1% | — | $81,000 | — |
| 11/12/2020 | $-0.26 | $-0.31 | -19.2% | — | $161,000 | — |
| 8/12/2020 | $-0.28 | $-0.23 | +17.9% | $22,608.7 | $20,000 | -11.5% |
| 5/14/2020 | $-0.24 | $-0.50 | -108.3% | $66,825 | $99,000 | +48.1% |
| 3/5/2020 | $-0.29 | $-0.15 | +48.3% | $795,600 | $459,000 | -42.3% |
| 11/14/2019 | $-0.23 | $-0.28 | -21.7% | $446,428.57 | Pending | — |
| 8/6/2019 | $-0.30 | $-0.18 | +40.0% | $777,777.78 | Pending | — |
| 5/7/2019 | — | $-0.42 | — | — | $500,000 | — |
| 3/25/2019 | — | $-2.24 | — | — | Pending | — |
| 12/20/2018 | — | $-0.52 | — | — | Pending | — |
| 6/30/2018 | — | $-0.55 | — | — | Pending | — |
| 3/31/2018 | — | $-0.54 | — | — | Pending | — |
| 12/31/2017 | — | $-2.01 | — | — | Pending | — |
| 9/30/2017 | — | $-0.50 | — | — | Pending | — |
| 6/30/2017 | — | $-0.69 | — | — | Pending | — |